SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-001518
Filing Date
2020-02-13
Accepted
2020-02-13 16:39:02
Documents
4
Period of Report
2020-02-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT vtgn8k_feb112020.htm 8-K 25893
2 PRESS RELEASE ex99-1.htm EX-99 177927
3 PRESS RELEASE ex99-2.htm EX-99 21218
4 IMAGE vtgn.jpg GRAPHIC 11058
  Complete submission text file 0001654954-20-001518.txt   236236
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 20611357
SIC: 2834 Pharmaceutical Preparations